phase readout
saveNCT06679270: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Familial Partial Lipodystrophy
view source ↗
comments(0)
5-min edit window · permanent after that